1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD,
http://seer.cancer.gov/csr/1975_2012/
, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.
2. Meester RGS, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121:2281–5. Predictive US Public Health analysis based upon mathematical modeling of what the total value to society and the healthcare system would be if colorectal cancer screening was improved to 80% of recommendations.
3. American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
4. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–7. Results of a global effort to generate a comprehensive molecular analysis of colorectal cancer revealing consistencies and opportunities for therapeutic intervention.
5. NCCN Clinical Practice Guidelines in Oncology™ (Rectal Cancer). V.3.2015. Accessed from the National Comprehensive Cancer Network website <
http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf
> on June 20, 2015.